grant

Role of cytomegalovirus class I homologue in interference with host NK cell responses - a potential antiviral target [ 2000 - 2002 ]

Also known as: Viral subversion of innate host immune responses - characterisation of novel targets for antiviral drugs

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/110287]

Researchers: Prof Geoffrey Shellam (Principal investigator)

Brief description A common property of herpesviruses such as cytomegalovirus is their ability to establish lifelong infection in their hosts. In humans, cytomegalovirus infection can lead to tissue damage in normal individuals and may cause severe disease and even be fatal in individuals with immature or compromised immune systems, such as newborns, AIDS patients, transplant recipients and people treated with chemotherapeutic drugs. The ability of these viruses to establish persistent infection and remain in association with the host for its lifetime is a consequence of their capacity to subvert normal host immune responses. This is achieved by destroying or mimicking the functions of molecules and-or pathways critical to normal host defence mechanisms. The viral gene product under investigation is similar to a cellular protein critical for the ability of immune cells to kill foreign and-or infectious agents. We will investigate the mechanisms by which this viral gene product interferes with the host's first line of defence against viral pathogens. The proposed studies will improve our understanding of the strategies used by viruses to escape normal host immune responses and hence provide insights into the rational design of antiviral drugs and vaccines. Since the viral protein under investigation is similar to a cellular protein essential for the ability of immune cells to kill foreign or infectious agents, an improved understanding of the mechanisms of action of this protein will continue to improve our understanding of cellular events which play a crucial role in immune responses involved not only in control of infection, but also in tumour growth and transplant survival. Thus, the proposed studies will provide valuable insight towards the development of new therapies for pathological conditions associated with the above.

Funding Amount $AUD 428,020.11

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]
ACN 633 798 857